Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

Maron et al. (Sun,) studied this question.

www.synapsesocial.com/papers/69bf40cea1c38a784fa0cfff — DOI: https://doi.org/10.1016/j.jacc.2022.10.020

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy· 2003 · 1,458 citations
2. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy· 2001 · 243 citations
3. Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy· 1998 · 166 citations
4. Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy· 2021 · 36 citations
5. Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With β-Blockade or Verapamil· 2013 · 172 citations